Clinical Evaluation

clinical

Clinical Evaluation Report (CER) and Clinical Evaluation Plan (CEP) under the EU MDR

The Clinical Evaluation Report (CER) and Clinical Evaluation Plan (CEP) are crucial components of the clinical evaluation process for medical devices, as outlined in the EU Medical Device Regulation (MDR 2017/745). This comprehensive process ensures the safety and performance of medical devices. Below is an in-depth exploration of both CER and CEP:

Clinical Evaluation Report (CER)

  • Overview of CER

    The CER is a document that presents the analysis and conclusions from the clinical evaluation of a medical device. It encompasses the assessment of relevant scientific literature, clinical experience, and clinical investigations related to the device. The CER must demonstrate that the device achieves its intended purpose without exposing users and patients to undue risk.

  • Content and Structure of CER

    A well-structured CER includes:

    • Device Description : Detailed information about the device, its intended purpose, and technical characteristics.
    • Clinical Background : Overview of the condition treated or diagnosed by the device, including current treatment and diagnosis options.
    • Literature Review : Analysis of current literature pertaining to the device, similar devices, and relevant medical conditions.
    • Analysis of Clinical Data : This includes data from clinical investigations, post-market surveillance, and post-market clinical follow-up (PMCF) studies. The data should be critically appraised for its validity, relevance, and robustness.
    • Risk-Benefit Analysis : A comprehensive evaluation of the clinical risks and benefits, derived from clinical data and the risk management process.
    • Conclusions : Summarizing the clinical evaluation and stating whether the device complies with relevant clinical requirements of the MDR.

  • CER Updates and Maintenance

    The CER is a dynamic document that needs regular updates. The frequency of updates depends on the device’s risk class, the nature of the device, and emerging clinical data. High-risk devices and devices with significant changes in design or intended use require more frequent updates. Regular updates ensure ongoing compliance with MDR and continuous assurance of device safety and performance.

Clinical Evaluation Plan (CEP)

  • Purpose of CEP

    The CEP outlines the strategy for conducting the clinical evaluation. It's a roadmap detailing how the clinical evaluation will be executed and serves as a foundation for the CER. The plan should be proportionate to the device's risk and nature and reflect the stage of the device in its lifecycle.

  • Key Components of CEP

    A comprehensive CEP includes:

    • Scope and Context : Definition of the device’s intended purpose and justification for its clinical evaluation.
    • Methodology : Detailed approach for literature review, data collection, and appraisal. This includes databases to be searched, inclusion and exclusion criteria, and methods for data extraction and analysis.
    • Clinical Data Evaluation : Strategy for collecting and evaluating clinical data from various sources, including clinical investigations, literature, and post-market sources.
    • Risk Management : Integration with the device’s risk management process, identifying any clinical risks that need to be addressed.
    • PMCF Strategy : If applicable, a plan for post-market clinical follow-up to collect additional clinical data post-market.
    • Timelines and Milestones : A schedule for the clinical evaluation process, including key milestones and deadlines.

  • Integration with the Quality Management System

    The CEP should be integrated into the manufacturer’s Quality Management System (QMS). This integration ensures that the clinical evaluation process is systematic, traceable, and that it adheres to regulatory requirements. The QMS should define how the CEP is developed, reviewed, and approved, ensuring consistency and compliance with the MDR.

  • Challenges in Developing CER and CEP

    Developing CER and CEP requires a deep understanding of the MDR, clinical methodology, and statistical analysis. It can be challenging for manufacturers to gather comprehensive and robust clinical data, especially for new or innovative devices. Maintaining the CER with up-to-date clinical data, in line with evolving regulations and standards, adds complexity.

  • Conclusion

    The CER and CEP are fundamental elements of the clinical evaluation process under the EU MDR. They demonstrate a device's safety and efficacy through rigorous analysis of clinical data. The thorough and ongoing clinical evaluation, as evidenced in these documents, is essential for ensuring that medical devices meet the high standards of safety, performance, and quality required for marketing in the EU. As challenging as they are to develop and maintain, CER and CEP play a pivotal role in protecting patient health and upholding public confidence in medical devices.